T0	Participants 48 66	oncologic patients
T1	Participants 252 268	cancer patients.
T2	Participants 743 769	cancer patients with pain.
T3	Participants 778 954	240 patients with diagnosed malignancy and pain > 3 days and average pain >or= 3/10 will participate in a cluster randomized trial on 18 wards in 2 German university hospitals.